BASELINE ACLF GRADE AND TREATMENT RESPONSE TO TERLIPRESSIN IN PATIENTS WITH HEPATORENAL SYNDROME

被引：0
|
作者：
Subramanian, Ram [1 ]
Olson, Jody [2 ]
Zafar, Zunaira [3 ]
Jamil, Khurram [4 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ Kansas Hosp Author, Kansas City, KS USA
[3] St Mary Hosp, Langhorne, PA USA
[4] Mallinckrodt Pharmaceut, Seattle, WA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1092
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [1] THE IMPACT OF MELD SCORE AND ACLF GRADE ON OUTCOMES OF HEPATORENAL SYNDROME FOLLOWING TREATMENT WITH TERLIPRESSIN AND ALBUMIN IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS
    Weinberg, Ethan M.
    Jamil, Khurram
    Deng, Richard
    Reddy, K. Rajender Rajender
    HEPATOLOGY, 2023, 78 : S1365 - S1366
  • [2] RESPONSE AND PREDICTORS OF RESPONSE TO TERLIPRESSIN IN PATIENTS WITH HEPATORENAL SYNDROME
    Owen, Emily
    Yeary, Julianne
    Juang, Paul
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [3] Impact of Acute-on-Chronic Liver Failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome
    Piano, S.
    Schmidt, H.
    Ariza, X.
    Amoros, A.
    Romano, A.
    Sola, E.
    Gerbes, A.
    Bernardi, M.
    Alessandria, C.
    Trebicka, J.
    Gustot, T.
    Nevens, F.
    Arroyo, V.
    Gines, P.
    Angeli, P.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E54 - E54
  • [4] Terlipressin for the treatment of hepatorenal syndrome in patients with cirrhosis
    Angeli, Paolo
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (03): : 241 - 248
  • [5] PREDICTORS OF RESPONSE AND OUTCOME TO TERLIPRESSIN IN PATIENTS WITH HEPATORENAL SYNDROME
    Vinit, S.
    Kumar, A.
    Sharma, P.
    Bansal, R. K.
    Tyagi, P.
    Bansal, N.
    Singla, V.
    Kumar, M.
    Ranjan, P.
    Sachdeva, M. K.
    Arora, A.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S386 - S386
  • [6] Predictors of Response and Outcome to Terlipressin in Patients With Hepatorenal Syndrome
    Vinit, S.
    Kumar, A.
    Sharma, P.
    Bansal, R.
    Tyagi, P.
    Bansal, N.
    Singla, V.
    Kumar, M.
    Ranjan, P.
    Sachdeva, M.
    Arora, A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : 1383 - 1383
  • [7] Predictors of Response to Terlipressin in Hepatorenal Syndrome
    Mindikoglu, Ayse L.
    Pappas, Stephen C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (07) : 1174 - 1174
  • [8] Hepatorenal syndrome treatment with terlipressin and albumin
    Hamilton M.
    Critical Care, 2 (1):
  • [9] Impact of Baseline Kidney Function in Determining the Efficacy of Terlipressin in Patients with Hepatorenal Syndrome
    Chae, Seung Yun
    Kim, Young Soo
    Kim, Yaeni
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [10] Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome
    Piano, Salvatore
    Schmidt, Hartmut H.
    Ariza, Xavier
    Amoros, Alex
    Romano, Antonietta
    Huesing-Kabar, Anna
    Sola, Elsa
    Gerbes, Alexander
    Bernardi, Mauro
    Alessandria, Carlo
    Scheiner, Bernhard
    Tonon, Marta
    Maschmeier, Miriam
    Sole, Cristina
    Trebicka, Jonel
    Gustot, Thierry
    Nevens, Frederik
    Arroyo, Vicente
    Gines, Pere
    Angeli, Paolo
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (11) : 1792 - +
12345